News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts. WEEKLY
Table III: Statistical comparison of dissolution profile of inclusion complexes.
Dissolution of pure GLZ and all other prepared systems (i.e., complexes and PMs) were carried out in demineralized water.
Table III reports the values for the percent of drug dissolved within 20 min (DP20min), mean dissolution time (MDT), and time to dissolve 50% of the drug (t50%). The data show that the onset of dissolution of pure GLZ is slow (DP20min value was 6.14%, and t50% > 2 h).
Figure 6: Drug-release profile of glipizide–HP–β–CD complexes.
Figure 6 shows dissolution profiles of pure GLZ, its PM, and inclusion complexes with HP–β–CD over a period of 120 min. The
dissolution rate of pure GLZ is low; 29.69% of the drug is dissolved in 120 min. Inclusion complexes of GLZ with HP–β–CD significantly
enhanced the dissolution rate of GLZ within 120 min, compared with PM and pure GLZ. PM with HP–β–CD also improved GLZ's rate
of dissolution. The highest improvement was obtained using a complex prepared through coevaporation.
MDT is the first datum for the cumulative dissolution process that provides an accurate drug-release rate. A high MDT value
indicates great drug-retarding ability (18). The MDT of pure GLZ was high (99.64 min). This value decreased greatly after
the authors prepared GLZ's inclusion complexes and PM with HP–β–CD, which indicated an increase in dissolution rate. Coevaporation
2:1 had the lowest MDT (12.91 min).
Comparisons between the release profiles of different samples of GLZ were made with similarity factor f2. Table III shows that the release profiles of GLZ from all samples (i.e., complexes and PMs of HP–β–CD) and from pure GLZ
were dissimilar; f2 values for these comparisons were less than 50. Coevaporation 2:1, which had a better in vitro dissolution profile, lower MDT, and lower f2 values, was selected for further formulation of as an EOPT.
Ritesh B. Patel is a lecturer in the Department of Pharmaceutics and Pharmaceutical Technology, S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Gujarat, India.
Articles by Ritesh B. Patel
Rakesh P. Patel is an associate professor in the Department of Pharmaceutics and Pharmaceutical Technology, S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Gujarat, India.
Articles by Rakesh P. Patel
Madhabhai M. Patel
Madhabhai M. Patel is a professor in the Department of Pharmaceutics, Kalol Pharmacy College, Kalol, Gujarat, India.
Articles by Madhabhai M. Patel
Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
21%
To all process for new products only
11%
To select process for new products only
25%
To select processes for both new and legacy products
